MMRGlobal Receives Fifth Patent Expanding Rights to Control of Online Medical Records

LOS ANGELES, CA--(Marketwire - Nov 26, 2012) - MMRGlobal, Inc. (OTCBB: MMRF) ("MMR") today announced that its fifth online medical records patent, U.S. Patent No. 8,321,240, is being issued from the United States Patent and Trademark Office on Tuesday, November 27th. As of the issuance, MMR will be the owner of five U.S. patents pertaining to Personal Health Records and other eHealth records, along with additional patents in at least 13 other countries of commercial interest. The newest patent significantly adds to the Company's growing Health Information Technology ("HIT") patent portfolio consisting of 360 issued and/or pending claims, many originating as far back as 2005, while further solidifying MMR's position in the online medical records market. MMR has already contacted and offered licenses to more than 1,000 hospitals, group practices, and EMR and PHR providers in letters, sales presentations and other public forums. Since the Company began sending notices, it has reached agreements with EMR vendor(s) and others who provide health IT products and is in conversations with hospitals, trade associations and nursing agencies with regard to selling or licensing of the Company's products and services or eHealth IP.

The Company's patents were designed and created to protect its core health IT business which includes the MyMedicalRecords PHR and MMRPro document management and scanning systems for healthcare professionals. The Company also provides online storage solutions under the MyEsafeDepositBox brand. MMR is making its proprietary technology available either by selling its products and services, or through a reasonable licensing program so as not to deprive healthcare professionals of the value of the MMR patented products and services. Company CEO Robert H. Lorsch is the inventor of all the eHealth patents owned by the Company.

The MMR patent portfolio pertains to communication of health information from healthcare providers to patients and users of web-based services for user management of medical records, including but not limited to Electronic Medical Records and Personal Health Records. The most recent patent expands existing patent coverage for communication of health information from healthcare providers to web-based services through multiple forms of electronic messaging which are standard in the Company's MyMedicalRecords.com PHR and MMRPro document management and imaging systems including voice, fax, email and other messaging services.

The Company has already signed license agreements valued at more than $30 million, of which more than $10 million has already been invoiced. According to Lorsch, "Unlike patent trolling firms that seek to monetize another organization's intellectual property, our patents cover services we currently offer to customers as part of our existing products. Our intellectual property is based upon our core business. We saw the opportunity to invent and protect a universally applicable Personal Health Record and other eHealth products and services many years ago when we started building them and took steps to protect our ideas globally."

About MMRGlobal, Inc.
MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. visit www.mmrglobal.com. View demos and video tutorials of the Company's products and services at www.mmrtheater.com.

Forward-Looking Statements
All statements in this press release that are not strictly historical in nature, including, without limitation, potential intellectual property enforcement actions, infringement claims, litigation or licenses, future performance, management's expectations, beliefs, intentions, estimates or projections, constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need," "possibility," "potential," "intend," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue," or the negative of these words. Actual outcomes of intellectual property enforcement actions, infringement claims, litigation or licensing transactions, results of operations and the timing of selected events may differ materially from the results predicted, and any reported results should not be considered as an indication of future performance. Such statements are necessarily based on assumptions and estimates and are subject to various risks and uncertainties, including those relating to the possible invalidity of the underlying assumptions and estimates and possible changes or developments in economic, business, industry, market, legal and regulatory circumstances and conditions and actions taken or omitted to be taken by third parties, including customers, suppliers, business partners, potential licensees, competitors and legislative, judicial and other governmental authorities and officials. Factors that could cause or contribute to such differences include, but are not limited to: unexpected outcomes with respect to intellectual property enforcement actions, claims of intellectual property infringement and general intellectual property litigation; our ability to maintain, develop, monetize and protect our patent portfolio for both the Company's health IT and biotechnology intellectual property assets in the U.S. and internationally; the timing of milestone payments in connection with licensing our intellectual property; our ability to establish and maintain strategic relationships; changes in our relationships with our licensees; the risk the Company's products are not adopted or viewed favorably by the healthcare community and consumer retail market; business prospects, results of operations or financial condition; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; the timing and volume of sales and installations; the length of sales cycles and the installation process; the market's acceptance of new product and service introductions; competitive product offerings and promotions; changes in government laws and regulations and future changes in tax legislation and initiatives in the healthcare industry; undetected errors in our products; the possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; risks related to a security breach by third parties; risks associated with recruitment and retention of key personnel; other litigation matters; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in the Company's filings with the Securities and Exchange Commission. The Company is providing this information as of the date of this release and, except as required by applicable law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.